Article

Olivia Newton-John wants to sing your song

Author(s):

Melissa Weber

Ever dreamed of having a legendary singer and actress perform a song you wrote on national television? Well, now's your chance. Kaleidoscope, a television special to raise awareness about cancer in women, will include a contest to find a song written by a cancer survivor that will be performed by Olivia Newton-John. The program will air on Thanksgiving Day on Fox. Who knew football would ever segue to a cancer special?Newton-John, a breast cancer survivor, and two-time survivor Mike Burg, of Edge Health, made the announcement during a press briefing on Sunday morning at ASCO's annual meeting. I'm working on getting more details on the event and how you can submit lyrics for the contest, so stay tuned.

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Related Content
green background with white text indicating FDA Approval, What You Need to Know
March 8th 2025

FDA Approves Biosimilars for Cancer-Related Skeletal Events

Alex Biese
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of cells.
March 7th 2025

177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset

Spencer Feldman
177Lu-edotreotide shows potential to extend progression-free survival in patients with grade 1 or 2 somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of woman with brown hair.
March 7th 2025

Challenging Cancer Stereotypes While Living with Follicular Lymphoma

Karen Cohn
Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.
Image of woman holding her chest.
March 7th 2025

BRCA1/2 Mutations May Associate With Better Chemo Response in TNBC

Alex Biese
Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in patients with BRCA1/2 mutations.